119th Congress · introduced in the Senate · Jun 9, 2026
Asal Sayas National Strategy on Young Adult Cancers Act
Official title from Congress.gov
Latest action (Jun 9, 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
1 citation.
CHILDREN'S CAUSE FOR CANCER · lobbying firm or registrant: I STREET ADVOCATES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 6, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
S. 705, The Innovation in Pediatric Drugs Act; Medicaid coverage for pediatric cancer, HR 8839, The Lainie Jones Comprehensive Cancer Survivorship Act; S.4717, The Asal Sayas National Strategy on Young Adult Cancers Act
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing